Weitao Yao

488 total citations
33 papers, 345 citations indexed

About

Weitao Yao is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Weitao Yao has authored 33 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 20 papers in Oncology and 11 papers in Surgery. Recurrent topics in Weitao Yao's work include Sarcoma Diagnosis and Treatment (22 papers), Vascular Tumors and Angiosarcomas (10 papers) and Cardiac tumors and thrombi (7 papers). Weitao Yao is often cited by papers focused on Sarcoma Diagnosis and Treatment (22 papers), Vascular Tumors and Angiosarcomas (10 papers) and Cardiac tumors and thrombi (7 papers). Weitao Yao collaborates with scholars based in China and United States. Weitao Yao's co-authors include Zhichao Tian, Jiaqiang Wang, Xiaohui Niu, Songtao Gao, Peng Zhang, Po Li, Xinhui Du, Yan Zheng, Peng Zhang and Jinpo Yang and has published in prestigious journals such as Journal of Clinical Oncology, Frontiers in Immunology and Frontiers in Pharmacology.

In The Last Decade

Weitao Yao

30 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weitao Yao China 12 157 129 77 73 49 33 345
Songtao Gao China 11 91 0.6× 79 0.6× 87 1.1× 61 0.8× 22 0.4× 38 305
Carole Le Hénaff France 13 87 0.6× 134 1.0× 50 0.6× 266 3.6× 37 0.8× 21 499
Chenguang Bai China 13 96 0.6× 166 1.3× 160 2.1× 149 2.0× 14 0.3× 52 478
Elisabeth Ohmann Germany 7 64 0.4× 61 0.5× 183 2.4× 106 1.5× 19 0.4× 7 491
Yasutaka Murahashi Japan 13 121 0.8× 85 0.7× 95 1.2× 79 1.1× 34 0.7× 54 462
Lucía Recio-Poveda Spain 12 150 1.0× 42 0.3× 102 1.3× 86 1.2× 27 0.6× 24 388
Esa Kauppila Finland 4 102 0.6× 80 0.6× 168 2.2× 285 3.9× 94 1.9× 4 548
Melanie Barz Germany 14 79 0.5× 49 0.4× 89 1.2× 70 1.0× 9 0.2× 40 468
Masashi Tamaoki Japan 10 97 0.6× 95 0.7× 118 1.5× 125 1.7× 82 1.7× 27 402
Jennifer E. Kim United States 12 74 0.5× 205 1.6× 141 1.8× 122 1.7× 9 0.2× 23 651

Countries citing papers authored by Weitao Yao

Since Specialization
Citations

This map shows the geographic impact of Weitao Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weitao Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weitao Yao more than expected).

Fields of papers citing papers by Weitao Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weitao Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weitao Yao. The network helps show where Weitao Yao may publish in the future.

Co-authorship network of co-authors of Weitao Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Weitao Yao. A scholar is included among the top collaborators of Weitao Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weitao Yao. Weitao Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Su, Qiang, et al.. (2025). The role and research progress of the MET signalling pathway in targeted therapy for osteosarcoma. Oncology Reviews. 19. 1615111–1615111. 1 indexed citations
2.
Yao, Weitao, Kang Cui, Songtao Gao, et al.. (2025). The outcomes and treatment strategies in metastatic soft tissue sarcoma treated with immunotherapy-based therapy: a three-center study. Frontiers in Immunology. 16. 1504117–1504117. 1 indexed citations
3.
Tian, Zhichao, Yang Yang, Yonghao Yang, et al.. (2024). Combining nanoparticle albumin-bound paclitaxel with camrelizumab in advanced soft tissue sarcoma: activity, safety, and future perspectives. Frontiers in Pharmacology. 15. 1335054–1335054. 2 indexed citations
4.
5.
6.
Falchook, Gerald S., Yan Liang, R. Donald Harvey, et al.. (2023). First-in-human phase 1 study of pimicotinib (ABSK021), a CSF-1R inhibitor, in patients with advanced solid tumors.. Journal of Clinical Oncology. 41(16_suppl). 3100–3100. 1 indexed citations
7.
Yao, Weitao & Xinhui Du. (2023). Study of microwave ablation in patients with unresectable soft tissue sarcoma.. Journal of Clinical Oncology. 41(16_suppl). e23545–e23545. 1 indexed citations
8.
9.
Tian, Zhichao & Weitao Yao. (2023). Chemotherapeutic drugs for soft tissue sarcomas: a review. Frontiers in Pharmacology. 14. 1199292–1199292. 24 indexed citations
10.
11.
Tian, Zhichao, Shuping Dong, Po Li, et al.. (2022). Efficacy and safety of sintilimab plus doxorubicin in advanced soft tissue sarcoma: A single-arm, phase II trial. Frontiers in Pharmacology. 13. 987569–987569. 7 indexed citations
12.
Yao, Weitao, et al.. (2022). Surgical Efficacy and Prognosis of 54 Cases of Spinal Metastases from Breast Cancer. World Neurosurgery. 165. e373–e379. 4 indexed citations
13.
Tian, Zhichao, Jiaqiang Wang, Jinpo Yang, et al.. (2021). Apatinib with doxorubicin and ifosfamide as neoadjuvant therapy for high-risk soft tissue sarcomas: a retrospective cohort study. Investigational New Drugs. 39(6). 1724–1731. 1 indexed citations
14.
Du, Xinhui, Wei Hua, Po Li, & Weitao Yao. (2020). Artificial Intelligence (AI) Assisted CT/MRI Image Fusion Technique in Preoperative Evaluation of a Pelvic Bone Osteosarcoma. Frontiers in Oncology. 10. 1209–1209. 11 indexed citations
15.
Tian, Zhichao, Yang Yang, Yonghao Yang, et al.. (2020). High cumulative doxorubicin dose for advanced soft tissue sarcoma. BMC Cancer. 20(1). 1139–1139. 27 indexed citations
16.
Tian, Zhichao, Fan Zhang, Po Li, et al.. (2020). Albumin-bound paclitaxel and gemcitabine combination therapy in soft tissue sarcoma. BMC Cancer. 20(1). 698–698. 15 indexed citations
17.
Yao, Weitao, Jiaqiang Wang, Peng Zhang, et al.. (2020). Preliminary evaluate the safety and efficacy of anlotinib in advanced sarcoma patients in multi-line therapy.. Journal of Clinical Oncology. 38(15_suppl). 11526–11526. 1 indexed citations
18.
Yao, Weitao, et al.. (2019). Efficacy and safety of apatinib in advanced sarcoma. Anti-Cancer Drugs. 30(7). 749–756. 14 indexed citations
19.
Gao, Songtao, et al.. (2015). Experimental research Different methods for inducing adipose-derived stem cells to differentiate into Schwann-like cells. Archives of Medical Science. 4(4). 886–892. 18 indexed citations
20.
Gao, Songtao, Yan Zheng, Weitao Yao, et al.. (2014). Comparison of morphology and biocompatibility of acellular nerve scaffolds processed by different chemical methods. Journal of Materials Science Materials in Medicine. 25(5). 1283–1291. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Songtao Gao Breakdown of academic impact, for papers by Carole Le Hénaff Breakdown of academic impact, for papers by Chenguang Bai Breakdown of academic impact, for papers by Elisabeth Ohmann Breakdown of academic impact, for papers by Yasutaka Murahashi Breakdown of academic impact, for papers by Lucía Recio-Poveda Breakdown of academic impact, for papers by Esa Kauppila Breakdown of academic impact, for papers by Melanie Barz Breakdown of academic impact, for papers by Masashi Tamaoki Breakdown of academic impact, for papers by Jennifer E. Kim
Rankless by CCL
2026